Tepotinib with an EGFR-tyrosine kinase inhibitor (TKI) in patients with EGFR-mutant MET-amplified NSCLC: A case series

Lam, WS; Le, XN; Eisert, A; Himpe, U; De Bondt, C; Mazieres, J; Petrini, I; Tho, LM; Ahmad, A; Chik, YKJ; Chung, W; Lee, K; Yang, TY; Hsia, TC; Joshi, K; Young, L; Berghoff, K; Vlassak, S; Karachaliou, N; van der Wekken, A

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022; 18 (): 83

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索